The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

COVID-19 has significantly emphasized the importance of reliable nucleic acid-based tools that can effectively detect and control the spread of infectious diseases. Herein, we report a plasmonic fiber ...

While it is accepted that extracellular vesicles (EVs)-mediated transfer of microRNAs contributes to intercellular communication, the knowledge about molecular mechanisms controlling the selective and ...

Biotinylated nucleotides have emerged as a powerful tool in molecular biology, enabling researchers to explore genetic materials with unprecedented precision and sensitivity. These modified ...

The CsCl/EtBr gradient centrifugation method fractionates DNA and RNA molecules based on their density, where EtBr labels the nucleic acid bands. 3 Scientists have used this technique to extract large ...

Nucleic Acid Isolation and Purification MarketThe Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from ...

SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Initiative (NATi) to advance ribonucleic acid (RNA ...

Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine ...

SAN DIEGO, November 07, 2024--Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research ...